Early Access — free while we kick the tires
EdgarHawk

Novo Holdings A/S

10% Owner

10% Owner

Latest: Insider buying · May 2026

2 filings analyzed · 2 companies · Latest 2026-05-05

Companies

Company Buys Sells Direction
Avalyn Pharma Inc. AVLN 2 0 Net buying
MapLight Therapeutics, Inc. MPLT 2 0 Net buying

Activity

May 2026
2026-05-05 Avalyn Pharma Inc. AVLN Cluster
high
Buy
555,555 shares
$9,999,990
Significance 7/10

Novo Holdings, a 10% owner, acquires 3.9M shares via conversion and open-market purchase; part of multi-insider buying cluster in newly listed stock.

Novo Holdings, an institutional holder with significant ownership, made a substantial acquisition combining a share conversion and open-market purchase totaling nearly four million shares. This transaction is noteworthy in part because it occurred alongside purchases by two other insiders within a two-week window—a pattern that stands out given the stock's very recent listing status. The stock is currently trading at its 52-week high following its IPO launch, which makes this accumulation at peak pricing somewhat unusual: institutional investors and insiders typically build positions during pullbacks rather than at the upper end of trading range. Novo's track record shows prior open-market purchases, making this part of an existing pattern of accumulation at this company rather than a first-time entry. The company fundamentals and operational trajectory warrant review alongside this large institutional commitment to assess whether the timing reflects conviction in long-term positioning or simply routine portfolio mechanics following the listing event.

October 2025
high
Buy
952,941 shares
$16,199,997
Significance 7/10

10% Owner Novo Holdings A/S bought 952,941 shares of MPLT at $17.00 ($16.2M) in newly public stock 4 days after listing

Novo Holdings A/S, a 10% owner, purchased 952,941 shares at $17.00 on 2025-10-28, just 4 trading days after MapLight's IPO, increasing its holdings to 3,686,622 shares from 2,733,681 shares. The transaction value of $16,199,997.00 represents a substantial commitment by the institutional shareholder in the immediate post-listing window. The current stock price of $18.37 places the purchase $1.37 below today's market level. As a significant pre-IPO holder executing a substantial buy in the earliest trading days post-listing, this activity may reflect institutional assessment of the near-term IPO valuation, though the recent listing timeline (4 trading days) limits any pattern comparison.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access